» Articles » PMID: 17543389

Clinical Characterization of Retinal Capillary Hemangioblastomas in a Large Population of Patients with Von Hippel-Lindau Disease

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 2007 Jun 5
PMID 17543389
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To report the epidemiology and ocular phenotype of retinal capillary hemangioblastomas associated with von Hippel-Lindau (VHL) disease in a large cohort of patients and to correlate patient and ocular characteristics to visual morbidity in this population.

Design: Cross-sectional study.

Participants: In 220 unrelated pedigrees, 335 patients affected with VHL disease and retinal capillary hemangioblastomas (RCHs) in at least 1 eye.

Methods: Demographics of the patient population were recorded and the ocular phenotype of each patient was obtained with a comprehensive ocular examination.

Main Outcome Measures: The patient population was characterized and the ocular phenotype described in relationship to tumor location, number, and extent of retinal involvement. Correlations between patient demographics, ocular phenotype, and visual function were analyzed.

Results: We detected RCHs unilaterally in 42.1% and bilaterally in 57.9% of patients. No correlation was detected between the age, gender, or laterality of involvement. Of involved eyes, 86.6% had tumors that could be individually visualized; of these, tumors were commonly found in the peripheral retina (84.7%) only, and less commonly in the juxtapapillary area (15.3%). The tumor count in the periphery averaged 2.5+/-1.8 per eye, with 25.2% of eyes having >1 quadrant of retinal involvement. Of involved eyes, 13.4% were enucleated or prephthsical; approximately 1 in 5 patients had > or =1 eyes so affected. Severe visual impairment (visual acuity < or =20/160) in affected eyes were more likely to be associated with increasing age, the presence of juxtapapillary lesions, and an increasing number and extent of peripheral lesions.

Conclusions: This large cohort of VHL patients with RCHs has enabled a systematic and quantitative characterization of the demographics, ocular features, and visual function in VHL disease. Clinical correlations between the visual morbidity and ocular features of the disease were also performed, producing measures that can help clinicians to estimate visual prognoses better based on the ocular phenotype of the disease.

Citing Articles

Unveiling a Variant in the Retinal Capillary Hemangioblastoma, Type II Granular Corneal Dystrophy, and Von Hippel-Lindau Families: Unlocking Potential for Early Intervention and Targeted Therapy.

Azimi F, Khakpour G, Sedaghat A, Mostafaiee F, Kasraei H, Naseripour M J Curr Ophthalmol. 2025; 36(2):205-209.

PMID: 40012800 PMC: 11856112. DOI: 10.4103/joco.joco_53_24.


Retinal capillary hemangioma in a pthisical globe: Late sequelae in a case of Von Hippel-Lindau (VHL) disease presenting with endophthalmitis.

Helmi H, Alsaad R, Alkhiary H, Alkatan H Int J Surg Case Rep. 2025; 127:110867.

PMID: 39809053 PMC: 11782811. DOI: 10.1016/j.ijscr.2025.110867.


Prevalence of Neurological Symptoms and Imaging Findings in Von Hippel-Lindau Patients Referred to Rasool Akram Hospital, 2018-2021.

Javadi S, Habibi S, Sedaghat A, Naseripour M, Yousefi M J Kidney Cancer VHL. 2024; 11(2):12-17.

PMID: 38779573 PMC: 11109760. DOI: 10.15586/jkcvhl.v11i2.313.


Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series.

Ercanbrack C, Elhusseiny A, Sanders R, Santos Horta E, Uwaydat S Am J Ophthalmol Case Rep. 2024; 33:102011.

PMID: 38374949 PMC: 10875190. DOI: 10.1016/j.ajoc.2024.102011.


ZEISS PLEX Elite 9000 Widefield Optical Coherence Tomography Angiography as Screening Method for Early Detection of Retinal Hemangioblastomas in von Hippel-Lindau Disease.

Lang S, Dreesbach M, Laich Y, Glatz A, Boehringer D, Grewing V Transl Vis Sci Technol. 2024; 13(2):8.

PMID: 38345551 PMC: 10866155. DOI: 10.1167/tvst.13.2.8.


References
1.
McCabe C, Flynn Jr H, Shields C, Shields J, Regillo C, McDonald H . Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes. Ophthalmology. 2000; 107(12):2240-8. DOI: 10.1016/s0161-6420(00)00422-x. View

2.
Singh A, Shields C, Shields J . von Hippel-Lindau disease. Surv Ophthalmol. 2001; 46(2):117-42. DOI: 10.1016/s0039-6257(01)00245-4. View

3.
Singh A, Nouri M, Shields C, Shields J, Smith A . Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease. Ophthalmology. 2001; 108(10):1907-11. DOI: 10.1016/s0161-6420(01)00758-8. View

4.
Dollfus H, Massin P, Taupin P, Nemeth C, Amara S, Giraud S . Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci. 2002; 43(9):3067-74. View

5.
Lonser R, Glenn G, Walther M, Chew E, Libutti S, Linehan W . von Hippel-Lindau disease. Lancet. 2003; 361(9374):2059-67. DOI: 10.1016/S0140-6736(03)13643-4. View